Fourth quarter and full year 2021 results
Fourth quarter and full-year 2021 results were reviewed by management during a live audio webcast with the financial community. The presentation was followed by a Q&A session.
Featuring
Paul Hudson
Chief Executive Officer
Jean-Baptiste de Chatillon
Chief Financial Officer
Bill Sibold
Specialty Care
Thomas Triomphe
Vaccines
Olivier Charmeil
General Medicines
Julie Van Ongevalle
Consumer Healthcare
John Reed
R&D
Roy Papatheodorou
General Counsel
Highlights
"Our performance in 2021 was impressive, across the business and in our scientific results. We are poised for success ahead."
Paul Hudson
Chief Executive Officer, Sanofi